ProteoNic BV was named best investors’ pitch by Tim Draper, founder and managing director of renowned American Venture Capitalist firm Draper Fischer Jurvetson. During the Holland Innovation conference in Utrecht, the Netherlands 20 selected early stage companies from the life science and high tech sectors like telecom, internet and IT were given the opportunity to pitch their proposition to Mr. Draper, Residex Venture Capital Network and Solid Ventures. The jury, chaired by Tim Draper, unanimously elected ProteoNic, one of the only two life science companies contending, as the number one pitch based on content, presentation and most promising proposition in a billion dollar market.
Tim Draper is listed number 7 on the Forbes Midas list (best dealmakers in high tech and life sciences) and is one of the foremost venture capitalist in the USA. His investment firm has USD 3.5 billion in capital commitments and is active world wide.